Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


11.06.2018

1 BJU Int
1 BMC Urol
2 Br J Radiol
1 Cancer
1 Cancer Res
1 Clin Cancer Res
1 Eur J Radiol
2 Eur Urol
1 Int J Radiat Oncol Biol Phys
1 J Urol
1 Oncogene
1 Oncology
1 Prog Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BJU Int

  1. KUANG AG, Nickel JC, Andriole GL, Castro-Santamaria R, et al
    Both acute and chronic inflammation are associated with lower perineural invasion in men with prostate cancer on repeat biopsy.
    BJU Int. 2018 Jun 6. doi: 10.1111/bju.14428.
    PubMed     Text format     Abstract available


    BMC Urol

  2. KARIBURYO F, Wang Y, Cheng IE, Wang L, et al
    Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study.
    BMC Urol. 2018;18:55.
    PubMed     Text format     Abstract available


    Br J Radiol

  3. NGUYEN TB, Ushinsky A, Yang A, Nguyentat M, et al
    Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer.
    Br J Radiol. 2018 Jun 5:20180091. doi: 10.1259/bjr.20180091.
    PubMed     Text format     Abstract available

  4. MARTIN JM, Supiot S, Keall PJ, Catton CN, et al
    Moderately hypofractionated prostate external-beam radiotherapy: an emerging standard.
    Br J Radiol. 2018;91:20170807.
    PubMed     Text format     Abstract available


    Cancer

  5. PRINTZ C
    Combined therapies improve survival in aggressive prostate cancer.
    Cancer. 2018;124:2470.
    PubMed     Text format    


    Cancer Res

  6. LI X, Wang X, Song W, Xu H, et al
    Oncogenic properties of NEAT1 in prostate cancer cells depend on the CDC5L-AGRN transcriptional regulation circuit.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-18-0688.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. ANTONARAKIS ES, Small EJ, Petrylak D, Quinn DI, et al
    Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association With Overall Survival.
    Clin Cancer Res. 2018 Jun 1. pii: 1078-0432.CCR-18-0638.
    PubMed     Text format     Abstract available


    Eur J Radiol

  8. CUOCOLO R, Stanzione A, Rusconi G, Petretta M, et al
    PSA-density does not improve bi-parametric prostate MR detection of prostate cancer in a biopsy naive patient population.
    Eur J Radiol. 2018;104:64-70.
    PubMed     Text format     Abstract available


    Eur Urol

  9. MEHRA N, Dolling D, de Bono J
    Reply to Vincenza Conteduca, Giorgia Gurioli, and Ugo De Giorgi's Letter to the Editor re: Niven Mehra, David Dolling, Semini Sumanasuriya, et al. Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant P
    Eur Urol. 2018 Jun 1. pii: S0302-2838(18)30364.
    PubMed     Text format    

  10. BHINDI B, Karnes RJ
    Novel Nonsteroidal Antiandrogens and Overall Survival in Nonmetastatic Castration-resistant Prostate Cancer.
    Eur Urol. 2018 Jun 1. pii: S0302-2838(18)30370.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  11. GOMEZ-ITURRIAGA A, Casquero F, Pijoan JI, Crook J, et al
    Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Apr 22. pii: S0360-3016(18)30696.
    PubMed     Text format     Abstract available


    J Urol

  12. GILL IS, Azzouzi AR, Emberton M, Coleman JA, et al
    Randomized Trial of Partial Gland Ablation with Vascular-Targeted Phototherapy versus Active Surveillance for Low-risk Prostate Cancer: Extended Follow-up and Analyses of Effectiveness.
    J Urol. 2018 Jun 1. pii: S0022-5347(18)43299-5. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


    Oncogene

  13. AL SHAREEF Z, Kardooni H, Murillo-Garzon V, Domenici G, et al
    Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0294.
    PubMed     Text format     Abstract available


    Oncology

  14. OWARI T, Miyake M, Nakai Y, Morizawa Y, et al
    Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Oncology. 2018 Jun 6:1-9. doi: 10.1159/000489218.
    PubMed     Text format     Abstract available


    Prog Urol

  15. RAICHI A, Marcq G, Fantoni JC, Puech P, et al
    [Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].
    Prog Urol. 2018 May 31. pii: S1166-7087(18)30085.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: